Skip to content

Evaluation of an mHealth Behavioural Intervention for the Self-Management for Type 2 Diabetes

Evaluation of an mHealth Behavioural Intervention for the Self-Management for Type 2 Diabetes Mellitus

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02370719
Enrollment
23
Registered
2015-02-25
Start date
2015-06-28
Completion date
2017-10-28
Last updated
2021-09-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes Mellitus

Keywords

Diabetes mellitus, Randomized controlled trial, Primary care, Physical activity, Lifestyle, Blood glucose, Mobile health, Hb A1c, Self-management

Brief summary

The purpose of this study is to evaluate a patient-centered diabetes self-management mobile application (app), which was developed with feedback from both patients and healthcare providers. During the 12 month randomized control trial, participants in the intervention group will be provided with a mobile phone and commercial home medical devices, such as a weight scale, glucometer and activity monitor. The measurements taken from the medical devices will wirelessly transfer to the mobile phone, where the app will assess the data and provide patients with actionable self-management knowledge. The proposed intervention may be helpful in increasing adherence to recommended self-care practices, improving self-efficacy, and enhancing the overall patient experience.

Interventions

BEHAVIORALMobile application for diabetes self-management

Sponsors

MOUNT SINAI HOSPITAL
CollaboratorOTHER
University of Toronto
CollaboratorOTHER
Canadian Institutes of Health Research (CIHR)
CollaboratorOTHER_GOV
University Health Network, Toronto
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* English-speaking individuals * Diagnosed with non-insulin requiring type 2 diabetes * Outpatients * Baseline A1c of 7.5% or higher

Exclusion criteria

* Patients who are deemed unable to use a mobile phone (e.g. due to vision problems), and/or to comply with home monitoring (e.g. suffering from anxiety or depression) * Diabetes duration \<1 year

Design outcomes

Primary

MeasureTime frame
Change in HbA1c from baseline to 12 monthsBaseline, 3, 6, 9 and 12 months

Secondary

MeasureTime frame
WeightBaseline, 3, 6, 9 and 12 months
Cholesterol (LDL and total)Baseline, 6 and 12 months
Medication changes3, 6, 9 and 12 months
Glycemic excursions3, 6, 9 and 12 months
Blood pressureBaseline, 3, 6, 9 and 12 months
Diabetes Distress ScaleBaseline, 6 and 12 months
Diabetes Empowerment ScaleBaseline, 6 and 12 months
Summary of Diabetes Self-Care ActivitiesBaseline, 6 and 12 months
BMIBaseline, 3, 6, 9 and 12 months

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026